Skip to main content

After her diagnosis in 2005, Lynne went through 3 tyrosine kinase inhibitors (TKIs) for Ph+ CML in chronic phase before joining the clinical trials for SCEMBLIX in 2015. She encourages patients who are struggling with side effects or falling short of treatment goals to ask their doctor if it’s time for a different medication.

Please note, Lynne cannot provide clinical advice or counseling. For medical questions, speak with your doctor.

Lynne is an actual patient who has been compensated by Novartis Pharmaceuticals Corporation for participating in the SCEMBLIX Peers program.


Watch videos of Lynne's answers

Is CML a “good cancer?”

What results have you seen with SCEMBLIX?

What is SCEMBLIX and what are the possible side effects?

Get the perspective of another SCEMBLIX Peer.


Hear about Al’s Experience

Al's experience

Important Safety Information

Before taking SCEMBLIX, tell your doctor about all your medical conditions, including if you:

  • have a history of inflammation of your pancreas (pancreatitis)
  • have a history of heart problems or blood clots in your arteries and veins (types of blood vessels)
  • are pregnant or plan to become pregnant. SCEMBLIX can harm your unborn baby ...

Approved Uses

SCEMBLIX is a prescription medicine used to treat adults with:

  • Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with 2 or more tyrosine kinase inhibitors (TKIs)
  • Ph+ CML in CP with the T315I mutation ...